Crossmark

Exploring imidazo[1,2-a]pyridine hybrids in cancer therapy: ADMET profiling, molecular docking, MD simulations and DFT calculations

Published Online: 2026-02-14

Authors

Shah, Drashti

Nagani, Afzal

Shah, Moksh

Patel, Ashish
License Information

Text and Data Mining valid from 2026-02-14

Version of Record valid from 2026-03-16
More Information

Article History

Received: 7 October 2025

Accepted: 5 February 2026

First Online: 14 February 2026

Declarations

:

: The authors declare no competing interests.

Document is current